Background: Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease. Endothelial dysfunction represents the earliest stage of atherosclerosis. Objective: To evaluate the influence of chronic inflammatory state on endothelial function in patients with RA by measuring endothelial reactivity in young patients with RA with low disease activity and without traditional cardiovascular risk factors. Methods: Brachial flow mediated vasodilatation (FMV), assessed by non-invasive ultrasound, was evaluated in 32 young to middle aged patients with RA (age (59 years), with DAS28 (3.2 and without overt cardiovascular disease, and in 28 age and sex matched controls. Results: Mean (SD) FMV was significantly lower in patients than in controls Conclusions: Young to middle aged patients with RA with low disease activity, free from cardiovascular risk factors and overt cardiovascular disease, have an altered endothelial reactivity that seems to be primarily related to the disease associated chronic inflammatory condition.
Abstract-Metabolic syndrome (MS) is increasingly recognized as an important cardiovascular risk factor in hypertension, but its influence on left ventricular (LV) mass and function in the 2 genders has not been specifically addressed. Among 618 nondiabetic, untreated hypertensive subjects, echocardiographically detected LV mass was significantly greater in subjects with MS. A significant interaction was observed between sex and the MS (PϽ0.003 for the multiplicative interaction term). Compared with women without the MS, those with the syndrome had a 24% greater LV mass (49.5Ϯ12 versus 40.0Ϯ10 gϫm Ϫ2.7 ; PϽ0.001), whereas the difference was only 9% in men (50.3Ϯ12 versus 46.1Ϯ10 gϫm Ϫ2.7 ; Pϭ0.003). A greater prevalence of LV hypertrophy was found in women (37% versus 14%; PϽ0.001) but not in men (39% versus 29%; Pϭ0.09) with the MS. After adjustment for the effect of age, body mass index, 24-hour systolic blood pressure, and several confounders, the MS was independently associated with a greater LV mass index in women (regression coefficient, 4.80; PϽ0.001) but not in men. Women with the MS also had a greater LV relative wall thickness (0.42Ϯ0.07 versus 0.39Ϯ0.07; Pϭ0.004) and a depressed afterload-corrected midwall fractional shortening (94.0Ϯ12% versus 101.0Ϯ13%; PϽ0.001) than women without the syndrome, whereas no differences emerged in men. We conclude that, in untreated hypertension, MS has a different impact on LV hypertrophy and function in men and women. The effect of MS is more pronounced in women and is partly independent from the effect of several hemodynamic and nonhemodynamic determinants of LV mass. Key Words: hypertrophy Ⅲ remodeling Ⅲ metabolism Ⅲ gender Ⅲ risk factors T he metabolic syndrome (MS), a clustering of lipid and nonlipid cardiovascular risk factors, is increasingly recognized as an independent predictor of cardiovascular disease in hypertension. 1 The notion that the MS may have different relative importance for atherogenesis and cardiovascular disease in the 2 genders arises from observations indicating that elevated triglycerides and decreased high-density lipoprotein cholesterol, 2 basic components of the syndrome, are better predictors of the risk of adverse outcomes in women than in men. [2][3][4] Moreover, in those studies in which the prognostic impact of the MS has been examined separately in men and women, the coronary or cardiovascular morbidity/mortality hazard ratios associated with the syndrome were almost invariably found to be higher in the female sex. 1,5-10 Similarly, Iglseder et al 11 have observed in a healthy population that the effect of MS on carotid intimamedia thickness is more pronounced in women than in men.Left ventricular (LV) hypertrophy, a major manifestation of hypertensive heart disease, is a strong and independent herald for cardiovascular morbidity and mortality, 12,13 and its treatment-induced regression has been unequivocally associated with an improved cardiovascular prognosis, even after accounting for the confounding effect of treatment-induced b...
Systolic blood pressure and pulse pressure, but not diastolic blood pressure, are predictors of plasma C-reactive protein concentrations in patients with newly diagnosed, never-treated hypertension, irrespective of the potential proinflammatory action of traditional cardiovascular risk factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.